SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001264124-05-000248
Filing Date
2005-09-30
Accepted
2005-09-30 14:38:31
Documents
2
Period of Report
2005-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2520
2 EDGAR SUPPORTING DOCUMENT easthampoa.txt EX-24 2118
  Complete submission text file 0001264124-05-000248.txt   6488
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIVERSA CORP 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 858 526 5166
EASTHAM KARIN (Reporting) CIK: 0001231845 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19700 | Film No.: 051113797